News
-
-
-
PRESS RELEASE
Encouraging New Data: Grafalon Benefits High-Risk Pediatric HSCT Patients in the FORUM Study
Neovii Pharmaceuticals AG announces new data from FORUM study showing Grafalon benefits high-risk pediatric HSCT patients. Study evaluates different serotherapy approaches for improved outcomes -
-
-
PRESS RELEASE
Giotto.ai and RUAG AG initiate cooperation to deploy award- winning AI reasoning technology
Giotto.ai and RUAG AG partner to deploy award-winning AI reasoning technology for advanced applications. Giotto.ai provides portable intelligence system to RUAG for integration into AI platform LLARA -
-
-
-